TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility
R. van Horssen, T.L.M. ten Hagen and A.M.M. EggermontThe Oncologist (2006), Vol. 11 pages 397-408
Functionalization of tumor necrosis factor-α using phage display technique and PEGylation improves its antitumor therapeutic window
H. Shibata, Y. Yoshioka, S. Ikemizu, K. Kobayashi, Y. Yamamoto, Y. Mukai, T. Okamoto, M. Taniai, M. Kawamura, Y. Abe, S. Nakagawa, T. Hayakawa, S. Nagata, Y. Yamagata, T. Mayumi, H. Kamada and Y. TsutsumiClinical Cancer Research (2004), Vol. 10 pages 8293-8300
Enhanced antitumor potency of polyethylene glycolylated tumor necrosis factor-α: a novel polymer-conjugation technique with a reversible amino-protective reagent
S. Tsunoda, T. Ishikawa, Y. Yamamoto, H. Kamada, K. Koizumi, J. Matsui, Y. Tsutsumi, T. Hirano and T. MayumiJournal of Pharmacology and Experimental Therapeutics (1999), Vol. 290 pages 368-372
Molecular design of hybrid tumor necrosis factor-α III: polyethylene glycol-modified tumor necrosis factor-α has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation
Y. Tsutsumi, T. Kihira, S. Tsunoda, H. Kamada, S. Nakagawa, Y. Kaneda, T. Kanamori and T. MayumiJournal of Pharmacology and Experimental Therapeutics (1999), Vol. 278 pages 1006-1011
In vivo anti-tumor efficacy of polyethylene glycol-modified tumor necrosis factor-α against tumor necrosis factor resistant tumors
Y. Tsutsumi, S. Tsunoda, Y. Kaneda, H. Kamada, T. Kihira, S. Nakagawa, Y. Yamamoto, Y. Horisawa and T. MayumiJapanese Journal of Cancer Research (1996), Vol. 87 pages 1078-1085
Molecular design of hybrid tumour necrosis factor α with polyethylene glycol increases its anti-tumour potency
Y. Tsutsumi, T. Kihira, S. Tsunoda, T. Kanamori, S. Nakagawa and T. MayumiBritish Journal of Cancer (1995), Vol. 71 pages 963-968
Intravenous administration of polyethylene glycol-modified tumor necrosis factor-α completely regressed solid tumor in Meth-A murine sarcoma model
Y. Tsutsumi, T. Kihira, S. Tsunoda, K. Kubo, M. Miyake, T. Kanamori, S. Nakagawa and T. MayumiJapanese Journal of Cancer Research (1994), Vol. 85 pages 1185-1188.
Chemical modification of natural human tumor necrosis factor-α with polyethylene glycol increases its anti-tumor potency
Y. Tsutsumi, T. Kihira, S. Yamamoto K. Kubo, S. Nakagawa, M. Miyake, Y. Horisawa, T. Kanamori, H. Ikegami and T, MayumiJapanese Journal of Cancer Research (1994), Vol. 85 pages 9-12
Tumour necrosis factor in man: clinical and biological observations
P. Selby, S. Hobbs, C. Viner, E. Jackson, A. Jones, D. Newell, A.H. Calvert, T. McElwain, K. Fearon and J. HumphreysBritish Journal of Cancer (1987), Vol. 56 pages 803-808
Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
K. Haranaka, N. Satomi and A. SakuraiInternational Journal of Cancer (1984), Vol. 34 pages 263-267
An endotoxin-induced serum factor that causes necrosis of tumors
E.A. Carswell, L.J. Old, R.L. Kassel, S. Green, N. Fiore and B.D. WilliamsonProceedings of the National Academy of Sciences (1975), Vol. 72 pages 3666-3670